The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or Vaccination

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new virus discovered in December 2019 that causes coronavirus disease 19 (COVID-19) and various vaccinations have been developed. The extent to which COVID-19 infections and/or COVID-19 vaccinations alter antiphospholipid antibodies (...

Descripción completa

Detalles Bibliográficos
Autores principales: Ott, Olivia, Herrmann, Eva, Schulz, Annabel, Lindhoff-Last, Edelgard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051980/
https://www.ncbi.nlm.nih.gov/pubmed/36982716
http://dx.doi.org/10.3390/ijms24065644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051980/
https://www.ncbi.nlm.nih.gov/pubmed/36982716
http://dx.doi.org/10.3390/ijms24065644

Ejemplares similares